AST
Asterias Biotherapeutics Inc. Series A
AST
AST
Delisted
AST was delisted on the 7th of March, 2019.
66 hedge funds and large institutions have $18.3M invested in Asterias Biotherapeutics Inc. Series A in 2016 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 18 increasing their positions, 10 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
14% less capital invested
Capital invested by funds: $21.2M → $18.3M (-$2.91M)
Holders
66
Holding in Top 10
1
Calls
$52K
Puts
–
Top Buyers
| 1 | +$4.94M | |
| 2 | +$751K | |
| 3 | +$741K | |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$155K |
| 5 |
TCIM
TIAA CREF Investment Management
New York
|
+$132K |
Top Sellers
| 1 | -$322K | |
| 2 | -$62K | |
| 3 | -$15.7K | |
| 4 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$9K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$5.85K |